📑Antineoplastika - Venetoclaxum
Procurement process summary
This process is to purchase Antineoplastika - Venetoclaxum.
This contract was awarded by 🇨🇿 Fakultní nemocnice Brno for an amount of CZK 34,980,256 to 1 supplier. It was published on 2019-12-23 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇨🇿 Fakultní nemocnice Brno Buying unitnot reported Publication date2019-12-23 Contest statusnot reported DescriptionPredmetem zadavaciho rizeni je uzavreni ramcove kupni smlouvy na dodavky lecivych pripravku dle potreb zadavatele.Awards
This award was granted to AbbVie s.r.o. by Fakultní nemocnice Brno for an amount of CZK 34,980,256. The procurement process was conducted through open for the category of goods. The award was granted on 2020-07-14. This is award number 1.
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇨🇿 AbbVie s.r.o. | CZK 34,980,256 | 2020-07-14 | 1 |
Market context and opportunities
The execution of this contract allows the entity Fakultní nemocnice Brno to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberCZ_ocds-70d2nz-fdf2e031-feea-4e5a-9d58-d58c07cdad7a-award-1Publication date2019-12-23Contract datenot reportedAward date2020-07-14CategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
